Clinical Resources
Materials for Providers
Alphabetical by Title
Standing orders for Administering Measles, Mumps, and Rubella Vaccine to Adults
Eligible healthcare professionals may vaccinate adults who meet any of the criteria on this form
Standing Orders for Administering Measles, Mumps, and Rubella Vaccine to Children and Teens
Eligible healthcare professionals may vaccinate children and teens who meet any of the criteria on this form
Materials for Vaccine Recipients
Alphabetical by Title
Rubella: Questions and Answers
Information about the disease and vaccines for patients and parents
CDC · FDA · State
ACIP Recommendations
Current Recommendations
Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices—United States, 2022
MMWR, November 18, 2022, 71 (46); 1465-1470
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 — Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, June 14, 2013; 62(RR04):1-34
Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine–Recommendations of the Advisory Committee on Immunization Practices
MMWR, May 7, 2010; 59(RR–3):1 – 16
Vaccine Information Statements
MMR (Measles, Mumps, Rubella) VIS
Updated: August 6, 2021
MMRV (Measles, Mumps, Rubella and Varicella) VIS
Updated: August 6, 2021
CDC Recommended Schedules
2024 Child and Adolescent Immunization Schedule
- Page count: 15
- Color
- Size: 8.5 ” x 11″
2024 Adult Immunization Schedule
- Page count: 13
- Color
- Size: 8.5 ” x 11″
FDA Package Inserts & EUAs
Measles, Mumps, Rubella: MMR II Package Insert
Merck & Co., Inc.
Measles, Mumps, Rubella: Priorix Package Insert
GSK
Combination Vaccine: ProQuad Package Insert
Merck & Co.
State Policies
U.S. map of MMR requirements
